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Based on experimental concentration depth profiles of the antiin-
flammatory drug dexamethasone in human skin, we model the
time-dependent drug penetration by the 1D general diffusion
equation that accounts for spatial variations in the diffusivity and
free energy. For this, we numerically invert the diffusion equa-
tion and thereby obtain the diffusivity and the free-energy pro-
files of the drug as a function of skin depth without further
model assumptions. As the only input, drug concentration pro-
files derived from X-ray microscopy at three consecutive times
are used. For dexamethasone, skin barrier function is shown to
rely on the combination of a substantially reduced drug diffu-
sivity in the stratum corneum (the outermost epidermal layer),
dominant at short times, and a pronounced free-energy barrier
at the transition from the epidermis to the dermis underneath,
which determines the drug distribution in the long-time limit. Our
modeling approach, which is generally applicable to all kinds of
barriers and diffusors, allows us to disentangle diffusivity from
free-energetic effects. Thereby we can predict short-time drug
penetration, where experimental measurements are not feasible,
as well as long-time permeation, where ex vivo samples deteri-
orate, and thus span the entire timescales of biological barrier
functioning.
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Multicellular organisms exhibit numerous structurally dis-tinct protective barriers, such as the blood–brain barrier;
intestinal, mouth, and respiratory mucosa; and the skin, the
largest human organ. These barriers are generally designed to
keep foreign material out and in some cases to allow the highly
regulated transfer of certain desired molecules; consequently,
they present a severe challenge for drug delivery (1–3). The in-
depth understanding of barrier function is not only required for
controlled drug delivery, but also of central interest in medicine,
drug development, and biology.
Human skin can be broadly divided into two layers (Fig.
1A): the epidermis with a thickness of about 100 µm, which
prevents water loss and the entrance of harmful microorgan-
isms or irritants, and the dermis, which is typically 2 mm thick,
contains blood vessels, and protects the body from mechani-
cal stress (4). The epidermis is further divided into the stra-
tum corneum (SC), the 10- to 20-µm thick outermost layer con-
sisting of dried-out dead skin cells, the corneocytes, and the
viable epidermis (VE). In the stratum granulosum (SG), which
is part of the VE, skin cells (keratinocytes) are gradually flat-
tened and transformed into corneocytes when migrating toward
the SC.
The SC is structurally similar to a brick wall (5): The bricks
are the corneocytes, whereas the mortar is the intercellu-
lar matrix, which is composed of stacked lipid bilayers. Sev-
eral models for the permeation of drugs through skin exist,
which incorporate the skin structure on different levels of com-
plexity. In the simplest models the stratified skin structure is
reflected by 1D layers with different diffusivities and partition
coefficients (6–10), and in more detailed models the 3D SC
structure is accounted for (11, 12). In all models a certain
skin structure and various transport parameters are assumed,
which a posteriori are adjusted, such as to reproduce experi-
mental permeabilities or concentration-depth profiles inferred
from tape-stripping studies (11, 12). For a detailed overview
of skin-diffusion models and a historical outline see refs. 13
and 14.
We describe here a data-based modeling approach, i.e., which
does not make any model assumptions and as the only input
requires drug concentration-depth profiles in the skin at three
consecutive times. Our approach, which we test for the lipophilic
antiinflammatory glucocorticoid dexamethasone (DXM) in ex
vivo human skin, is very general and can be used for all kinds
of permeation barriers. This drug is chosen because soft X-ray
absorption spectromicroscopy allows us to generate 2D absolute
concentration profiles of unlabeled DXM in thin skin slabs with
a resolution below 100 nm (15, 16).
We start with the general 1D diffusion equation, which
describes the evolution of a 1D concentration profile c(z , t) in
space and time and depends on the position-dependent free-
energy profile F (z ) and the diffusivity profile D(z ),
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c(z , t)eβF(z)
)
, [1]
where β= 1/(kBT ) is the inverse thermal energy. The free-
energy profile F (z ) reflects the local affinity and determines how
the substance, in our specific case DXM, partitions in equilib-
rium, namely ceq(z )∝ e−βF(z). The diffusivity profile D(z ) is
a local measure of the velocity at which the substance diffuses
in the absence of external forces. The diffusion equation not
only describes passive and active particle transport in structured
media, it has in the past also been used for modeling marketing
strategies (17), decision making (18), and epigenetic phenotype
fluctuations (19). The importance of a spatially varying diffusivity
profile D(z ) has been recognized for the relative diffusion of two
particles (20), transmembrane transport (21), particle diffusion
at interfaces (22, 23), protein folding (24–27), and multidimen-
sional diffusion (28). The 1D diffusion equation can be solved
analytically only in simple limits; for general F (z ) and D(z ) pro-
files the solution c(z , t) must be numerically calculated.
The inverse problem, i.e., extracting F (z ) and D(z ) from sim-
ulation or experimental data, is much more demanding and has
recently attracted ample theoretical attention. With one notable
exception (29), most inverse approaches need single-particle
stochastic trajectories and are not suitable to extract informa-
tion from concentration profiles (20–22, 30–32). For the typi-
cal experimental scenario, where a few concentration profiles at
different times are available, we here present a robust method
that yields the F (z ) and D(z ) profiles with minimal numeri-
cal effort and for general open boundary conditions (Materi-
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Fig. 1. (A) Schematic of epidermal skin structure. (B) Normalized 2D-
transmission intensity profiles from X-ray scanning microscopy at photon
energy 530.1 eV after 10 min, 100 min, and 1,000 min penetration time. The
profiles allow us to distinguish different skin layers, schematically indicated
by white dividing lines, and demonstrate the skin sample variation. Whereas
the SC has a rather uniform thickness, the VE thickness varies considerably
between the three samples.
als and Methods). We demonstrate our method using experi-
mental 1D concentration-depth profiles of DXM, a medium-size
drug molecule that in water is only poorly soluble (33). Starting
the drug penetration by placing a 1.5% DXM formulation in a
hydroxethyl cellulose (HEC) gel on top of excised human skin at
time 0, 2D concentration profiles of DXM in the epidermal skin
layer are obtained after penetration times of 10 min, 100 min,
and 1,000 min, using soft X-ray absorption spectromicroscopy
(15, 16) (Materials and Methods).
To determine both the free-energy profile F (z ) and the dif-
fusivity profile D(z ) in the epidermal skin layer as well as the
diffusive DXM properties in the drug-containing HEC gel and
in the dermis, we need three experimental concentration pro-
files recorded at different times as input. We demonstrate that
both the diffusivity profile D(z ), which dominates drug pene-
tration for short times, and the free-energy profile F (z ), which
dominates long-time drug concentration profiles, are needed to
describe drug penetration quantitatively.
Our analysis reveals that skin barrier function results from
an intricate interplay of different skin layer properties: Whereas
the entrance of lipophilic DXM into the SC is free-energetically
favored, the drug diffusivity in the SC is about 1,000 times lower
than in the VE and thus slows down the passage of DXM through
the SC. In addition, a pronounced free-energy barrier from the
epidermis to the dermis prevents DXM from penetrating into
the lower dermal layers. In essence, the epidermis has a high
affinity for the lipophilic drug DXM, which together with the low
diffusivity in the SC efficiently prevents DXM penetration into
the dermis.
Results and Discussion
Experimental Concentration Profiles. Fig. 1B shows 2D absorption
profiles recorded at photon energy 530.1 eV for penetration
times of 10 min, 100 min, and 1,000 min. This photon energy
selectively excites DXM (15). The skin-depth coordinate z is
shifted such that the outer skin surface is aligned to z = 0. The
color codes the transmitted intensity, with blue indicating low
and yellow high transmission, and allows insights into the skin
structure. Note that the three profiles originate from different
skin samples from the same donor, because the analysis of the
identical skin sample for different penetration times is not possi-
ble (16). Accordingly, these three samples have been chosen for
maximal similarity of the SC and VE thicknesses.
The region below z < 0 µm is the Epon resin used for skin
embedding. For all three samples, the layered structure from
z ≈ 0µm to z ≈ 10µm is the SC, whereas the VE extends
from a depth of about z ≈ 10 µm to a variable depth ranging
from z ≈ 50 µm to z ≈ 80 µm. Within the VE oval-shaped ker-
atinocyte nuclei are discerned, which move gradually toward the
SC where they differentiate and flatten into corneocytes. The
dermis, separated from the VE by the basal layer and the basal
membrane, is clearly distinguished from the VE by the differ-
ent transmission intensity. Note that the variation of the VE
thickness across different samples is an inherent property of skin
and must be kept in mind in the analysis. From the ratio of the
2D transmission profiles at photon energies of 530.1 eV and
528.0 eV the 2D concentration profiles of DXM are determined
(15, 16) (see Materials and Methods, DXM Concentration Profiles
from X-Ray Microscopy, and Figs. S1 and S2 for details).
Our aim is not to describe DXM diffusion at the cellular
level, for which 3D concentration profiles at different penetra-
tion times of the same sample would be needed; our goal rather
is to model the 1D diffusion of DXM from the HEC gel on the
skin surface through the epidermis into the deeper skin layers.
For this, we laterally average the experimental 2D concentra-
tion profiles; the resulting 1D concentration data are shown in
Fig. 2A (black solid circles). We base our modeling on cubic
smoothing spline fits (black lines) in the range 0< z < 80 µm,
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Fig. 2. (A) One-dimensional experimental DXM concentration profiles at three different penetration times (black solid circles) and cubic smoothing splines
(black lines) are compared with theoretical predictions based on the diffusion equation (red lines). Vertical dividing lines indicate skin layers and are based
on the 2D transmission intensity profiles in Fig. 1B. (B and C) Free-energy profile F(z) (B) and diffusivity profile D(z) (C) derived from the experimental
concentration profiles. F(z) is low in the entire epidermis (SC and VE) compared to the HEC gel and to the dermis and exhibits a small but significant gradual
increase in the SC (B, Inset), and the epidermis thus exhibits lipophilic affinity. D(z) is low in the SC and increases by a factor of 1,000 in the VE, where it is
close to the free-solution value. The low diffusivity in the SG in the depth range 10 µm < z< 15 µm could indicate the presence of tight junctions. In the
gel and beyond z= 80 µm (indicated by a vertical dashed line) the F(z) and D(z) profiles are approximated as constant. (D) Integrated amount of DXM in
the epidermis Cepi from experiments (black solid circles) and theory (red line), showing a maximum at penetration time t≈ 6 × 104 s= 1,000 min (Inset)
before it relaxes to the predicted stationary value indicated by a horizontal dashed line.
disregarding residual DXM in the Epon resin for z < 0 µm as
well as the range z > 80 µm where only a single concentration
profile is available. It is seen that already after 10 min penetra-
tion DXM has entered the SC. After 100 min penetration DXM
is found in the VE, whereas the concentration in the SC has
not changed much. The difference between the 100-min and the
1,000-min profiles is seen to be rather small.
Extracting Free-Energy and Diffusivity Profiles. Feeding the three
experimental DXM concentration profiles in the depth range
0< z < 80 µm after 10 min, 100 min, and 1,000 min penetration
time into our inverse solver for the diffusion equation, we derive
the best estimates for the F (z ) and D(z ) profiles shown in Fig.
2 B and C; in the gel and in the dermis, due to the absence of
experimental data, we approximate F (z ) and D(z ) to be con-
stant. The error bars reflect the SD of the estimates that pass the
error threshold σ< 0.6 µg/(cm2·µm) (see Materials and Methods
for more details).
The free energy F (z ) in Fig. 2B, approximated to be con-
stant in the gel and set to Fgel = 0, exhibits a jump down by
∆Fgel/SC≈−8.6 kJ/mol at the boundary between gel and SC. This
is in line with the lipophilic character of DXM, which prefers
to be in the lipid-rich SC compared with the HEC gel formu-
lation. In the SC, the free energy increases rather smoothly by
≈ 1.5 kJ/mol over a range of 10 µm (Fig. 2B, Inset), reflect-
ing a significant structural change across the SC that sustains
the steep water chemical potential gradient across the SC (34).
In the depth range 10 µm < z < 50 µm, which corresponds
to the VE, the free energy is rather constant. In the range
50 µm < z < 80 µm the free energy slightly increases again,
which reflects the decreasing DXM concentration in the experi-
mental profiles in Fig. 2A for 100 min and 1,000 min. Compar-
ison with the transmission intensity profiles in Fig. 1B reveals
that this free-energy increase is caused by the transition from the
epidermis to the dermis, which due to skin sample variations is
smeared out over a broad depth range of 50 µm < z < 80 µm.
The free-energy jump of ∆FVE/derm≈ 20.5 kJ/mol at z = 80µm
reflects a pronounced barrier for DXM penetration into the der-
mis related to the different DXM affinity to the dermis com-
pared with the VE. Due to data scattering this value constitutes
a lower bound, as is explained in Estimate of Free-Energy Bar-
rier Height Between Epidermis and Dermis and Fig. S3. In fact,
the free-energy difference between the HEC gel and the dermis,
∆Fgel/derm≈ 16.2 kJ/mol = 6.4 kBT , is quite close to the free-
energy difference derived from the maximal DXM solubility in
water, cH2O = 89 mg/L at 25
◦C (35), and the DXM solubility in
the HEC gel cgel = 15 g/L, via the partition coefficient accord-
ing to kBT ln(cgel/cH2O) = 5.1kBT . The free-energy profile thus
identifies the dermis as essentially water-like, whereas the epi-
dermis is a sink with high lipophilic affinity, in line with previous
conclusions (36).
The constant diffusivity in the HEC gel turns out to be
Dgel≈ 16 µm2/s and drops in the SC by a factor of roughly 80 to
DSC≈ 0.2 µm2/s (Fig. 2C). The diffusivity maintains such a low
value up to a depth of z = 15 µm, where it abruptly increases.
For z ≥ 15 µm D(z ) exhibits a rather constant value of DVE≈
400 µm2/s, which is significantly larger than the value in the
HEC gel and somewhat smaller than the estimated diffusion con-
stant of dexamethasone in pure water, DH2O≈ 680 µm2/s (33).
We tentatively associate the layer 10 µm < z < 15 µm, where
the diffusivity is as low as in the SC but structurally is distinct
from the SC and belongs to the VE, with the SG. Note that
the SG, which is known to be located right below the SC, is
not visible in the transmission profiles in Fig. 1. The SG barrier
Schulz et al. PNAS | April 4, 2017 | vol. 114 | no. 14 | 3633
function has been shown to be due to tight junctions (37–40),
in line with the low local diffusivity in this region displayed in
Fig. 2C.
Summarizing, four distinct features are revealed by our anal-
ysis: (i) a low diffusivity in the SC, (ii) a low diffusivity in a thin
layer just below the SC that we associate with the SG, (iii) a sud-
den drop in free energy from the gel to the SC and a slight but
significant free-energy increase in the SC, and (iv) a pronounced
free energy barrier from the epidermis to the dermis. We stress
that these features in the free-energy and diffusivity profiles are
not put in by way of our analysis method, but rather directly fol-
low from the experimental concentration profiles. We note in
passing that the steep increase of the diffusivity at the bound-
ary from the putative SG (with DSG≈ 1 µm2/s) to the VE (with
DVE≈ 400 µm2/s) is nothing one could directly identify from the
experimental concentration profiles shown in Fig. 2A.
Predicting Concentration Profiles. In Fig. 2A we demonstrate that
the numerical solutions of the diffusion equation (red lines),
based on the free-energy and diffusivity profiles F (z ) and D(z )
in Fig. 2 B and C, reproduce the experimental concentration pro-
files very well (black lines). Small deviations are observed for the
drug-concentration profile after 10 min penetration time, and the
agreement is almost perfect for the 100-min and 1,000-min pro-
files. This not only means that our method for extracting F (z )
and D(z ) from concentration profiles works; we also conclude
that the diffusion equation Eq. 1 describes the concentration
time evolution in skin very well.
We define the time-dependent integral DXM amount that has
penetrated into the epidermis over the distance range 0< z <
80 µm as
Cepi =
∫ 80 µm
0 µm
c(z )dz . [2]
In Fig. 2D we compare the experimental data for Cepi (solid
black circles), which are directly obtained by integrating over the
experimental concentration profiles in Fig. 2A, with the theoret-
ical prediction based on the diffusion equation and the deter-
mined F (z ) and D(z ) profiles (red line). Note the logarithmic
timescale that extends from t = 1 s to t = 108 s ≈3 y. According
to the experimental protocol, at time t = 0 the entire amount of
DXM, corresponding to a surface concentration of 600 µg/cm2,
is located in the gel and thus Cepi is zero. With increasing time,
the theoretically predicted Cepi increases gradually and reaches
a maximum of Cepi = 471.9 µg/cm2 at t ≈ 6× 104 s = 1,000 min,
at which time only ≈1.2 µg/cm2 DXM has penetrated into the
dermis [Calculating the DXM Penetration Amount from Estimated
F(z) and D(z) Profiles]. In the long-time limit, which is reached
above t ≈ 107 s≈ 115 d, as seen in Fig. 2D, Inset, theory predicts
the equilibrium value C eqepi = 465.0 µg/cm
2, denoted by a horizon-
tal dashed line. In this hypothetical limit, longer than the exfoli-
ation time of skin, which is 30–40 d, theory predicts that ≈10.0
µg/cm2 DXM has penetrated into the dermis, whereas ≈125.0
µg/cm2 DXM still resides in the gel [see Calculating the DXM
Penetration Amount from Estimated F(z) and D(z) Profiles for the
full calculation]. Note that in vivo, dermal blood perfusion is cru-
cial and could be easily taken into account in a generalized diffu-
sion model by an additional reaction term.
The theoretically predicted curve for Cepi in Fig. 2D agrees
well with the experimental data, which is not surprising in light
of the good agreement of the concentration profiles in Fig. 2A.
This indicates that also the short- and long-time DXM penetra-
tion amounts, which are difficult to extract experimentally, are
straightforwardly obtained from our model.
In Fig. 3 we show calculated DXM concentration depth pro-
files for a wide range of times. We here also plot the predicted
concentration profiles in the gel and below the epidermis, for
-400 -200
c 
[
g/
(cm
2
m
)]
10 -4
10 -2
10 0
10 2
gel
z skin depth [ m]
20 40 60
viable epidermis (VE)
SC
10,000 20,000
0s
1s
1min
10min
1000min
7d
stat.
80
Fig. 3. Comparison of theoretical DXM concentration profiles for a wide
range of different penetration times. At time 0 the drug is entirely in the
gel. Already at t = 1 s DXM penetrates into the SC. At intermediate times
t = 1 min and t = 10 min the VE is gradually filled, whereas at longer times
t = 1,000 min and t = 7 d the profile below the epidermis approaches the
stationary profile (indicated by a dotted curve).
which no experimental data are available. We see that for short
penetration times the concentration profile in the HEC gel is
inhomogeneous, so the simplifying assumption of a constant con-
centration in the gel becomes invalid. Interestingly, already at
t = 1 s DXM enters the SC. The 1,000-min profile is indistin-
guishable from the stationary profile in the HEC gel and the epi-
dermis, whereas below the epidermis, extending from z = 80 µm
to z = 2 cm, even after 7 d the stationary (flat) concentration pro-
file has not yet been reached (note the inhomogeneous depth
scale and the logarithmic concentration scale). Not surprisingly,
molecular diffusion over a macroscopic length scale of 2 cm takes
a long time.
Checking Model Validity. We check the robustness of our diffu-
sion model by comparison with two simplified models. In the
constant-F model we restrict the free energy in the epidermis to
be constant (with the diffusivity still being a variable function),
whereas in the constant-D model we restrict the diffusivity in
the epidermis to be constant (with the free energy being a vari-
able function). This means that the number of adjustable model
parameters drops from 162 in the full model down to 83; other-
wise we use the same methods for finding inverse solutions of the
diffusion equation as before (Materials and Methods).
The free-energy profiles of the constant-F (blue) and the
constant-D (green) models in Fig. 4A are rather similar and do
not differ much from the full model result (red); in particular,
the free-energy jumps from the HEC gel to the SC and from the
VE to the dermis come out roughly the same. The diffusivity pro-
file of the constant-F model in Fig. 4B is again similar to the full
model, whereas the constant-D model obviously misses the dif-
fusivity jump from the SC to the VE region.
When we look at the predicted DXM concentration profiles in
Fig. 4C, we clearly see the shortcomings of the restricted models:
The constant-F model (blue lines) correctly predicts the short-
time behavior including the 10-min profile, but fails severely for
the long penetration time of 1,000 min, which is close to the
stationary equilibrium limit. In contrast, the constant-D model
(green line) produces a concentration profile for 1,000 min that
is indistinguishable from the full model and thus describes the
experimental profile very nicely, whereas it fails at the short pen-
etration time of 10 min. The comparison of the full model to the
restricted models demonstrates that both the free-energy and the
diffusivity profiles are needed to correctly describe the experi-
mental concentration profiles over the entire penetration time
range from 10 min to 1,000 min. We also understand from this
comparison that the diffusivity profile is important at penetration
times up to 10 min, whereas the free-energy profile is required to
describe the long-time and the equilibrium behavior accurately.
3634 | www.pnas.org/cgi/doi/10.1073/pnas.1620636114 Schulz et al.
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the experimental long-time concentration profiles for penetration times 100 min and 1,000 min, and the constant-D model fails to predict the short-time
concentration profile 10 min.
A robustness check by comparison with results obtained from
a reduced dataset is shown in Bootstrapping Analysis and Fig. S4,
from which we conclude that the model is able to correctly pre-
dict concentration profiles even for times at which limited data
are provided.
Conclusions
A method for deriving free-energy and diffusivity profiles from
experimental concentration profiles at three different penetra-
tion times of drugs in human skin is presented. The approach is
generally applicable to all kinds of barrier situations and differ-
ent diffusors whenever spatially resolved concentration profiles
at different times are available and can also be generalized to
higher dimensions. For the specific example of DXM penetrat-
ing into human skin, our results demonstrate that both diffusiv-
ity and free-energy profiles are important to describe the skin
barrier: The inhomogeneous free-energy profile is essential to
correctly describe the long-time concentration profiles, whereas
the diffusivity profile is needed for reproducing the short-time
drug penetration. Epidermal skin barrier function against the
permeation of DXM is shown to rely on the combination of
two key properties, namely a low diffusivity in the SC and a low
free energy (i.e., high solubility) in the entire epidermis. Each of
these properties by itself severely reduces the DXM permeation
through the epidermis, but it is the combination that leads to the
exceptionally low and slow DXM transport into the dermis.
The design of efficient drug delivery methods through the epi-
dermis thus meets two challenges: First, the low diffusivity in
the SC needs to be overcome. And second, the free-energy bar-
rier from the epidermis, which we show to have pronounced
lipophilic affinity, to the hydrophilic dermis severely slows down
the permeation of lipophilic drugs. The remedy could consist
of modified drugs with balanced lipophilic–hydrophilic charac-
ter such that the epidermis–dermis affinity barrier is small or
even absent.
Materials and Methods
Experimental Concentration Profiles. Our studies were detailed previously
(15, 16) and use ex vivo human 2-cm-thick abdominal skin samples. The study
was approved by the Ethics Committee of the Charite´ Clinic Berlin (approval
EA/1/135/06, updated July 2015). It was in accordance with the Declaration
of Helsinki guidelines and the samples were obtained after the signed con-
sent of the patients. The skin surface was exposed to a 0.4-mm-thick layer of
a 70% ethanol HEC gel formulation containing DXM with a concentration
of cgel(t = 0) = 1.5 mg/(cm
2·mm) for penetration times of 10 min, 100 min,
and 1,000 min at a temperature of 305 K in a humidified chamber at the
saturation point. After gently removing the HEC gel, samples were subse-
quently treated in 2.5% glutaraldehyde in 0.1 M Na-cacodylate buffer and
with K4[(Fe(CN)6] and OsO4 for lipid and DXM fixation, dehydrated, embed-
ded in epoxy resin, sliced into sections of 350-nm thickness, and placed on sil-
icon nitride membranes of 100-nm thickness. X-ray microscopy studies were
performed at the synchrotron radiation facility BESSY II (Berlin, Germany)
in a scan depth range of 100 µm with a step width of 200 nm. The photon
energy was tuned to probe exclusively DXM at 530.1 eV via the O 1s→pi?
transition (16). This allows us to derive the absolute local DXM concentra-
tion by using Beer–Lambert’s law; see refs. 15 and 16 for details.
Numerical Solution and Inversion of Diffusion Equation. For the numerical
solution the diffusion Eq. 1 is discretized in space and time and takes the
form of a Master equation (41)
ci(t + ∆t)− ci(t)
∆t
= Wi,i−1ci−1(t) + Wi,i+1ci+1(t) + Wi,ici(t), [3]
where ∆t is the time discretization step. We match different spatial dis-
cretization schemes: Because experimental concentration data are available
at micrometer resolution in the epidermis up to a skin depth of 80 µm, we
use an equidistant discretization with ∆z= 1 µm in the range 0< z< 80
µm. For the transition rates we use (41)
Wi,j =
Di + Dj
2(∆z)2
exp
(
− Fi − Fj
2kBT
)
with j = i ± 1 [4]
and Wi,i =−Wi−1,i −Wi+1,i , which satisfies concentration conservation and
detailed balance. We thus have 2×80 = 160 parameters from the discretized
F(z) and D(z) profiles in the epidermal layer. In the HEC gel, which serves
as the DXM source during the penetration, no experimental concentration
data are available. We discretize the HEC gel with seven sites and a total
thickness of 0.4 mm, as in the experiment. We discretize the dermis and the
subcutaneous layer, for which also no experimental concentration data are
available, with 15 sites and a total thickness of 2 cm, as in the experiment.
The total number of discretization sites is N= 102. The free energies Fgel and
Fderm and the diffusivities Dgel and Dderm in the HEC gel and the subepider-
mal layer are assumed to be constant and are treated as free-fitting param-
eters. Reflective boundary conditions are used at the upper gel surface and
at the lower subdermal boundary, as appropriate for the experimental con-
ditions. The total number of parameters is reduced from 164 to 162 due to
the fact that only free-energy differences and diffusivity sums of neighbor-
ing sites enter Eq. 4. For more details see Variable Discretization of the 1D
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Diffusion Equation. The concentration profile ci(t) at time t = n∆t follows
from Eq. 3 as
ci(t) =
N∑
j=1
[
(1 + ∆tW)n
]
i,jcj(0) =
N∑
j=1
etWi,j cj(0), [5]
whereW is the rate matrix defined in Eq. 4 and the continuous limit ∆t→ 0
has been taken to express the nth power by the matrix exponential. Eq.
5 can be used to numerically solve the diffusion equation for any initial
distribution cj(t = 0) and diffusivity and free-energy profiles D(z) and F(z).
To determine D(z) and F(z) based on experimental concentration profiles at
different times, we minimize the squared sum of deviations
σ
2
=
1
Np
Np∑
k=1
1
Ndatak
Ndatak∑
i=1
cexpi (tk)− N∑
j=1
e
tkW
i,j cj(0)
2, [6]
where Ndatak is the number of experimental concentration data per profile
and Np = 3 is the number of experimental concentration profiles. We use
Ndata1 = 73 data points for the 10-min profile and N
data
2 =N
data
3 = 80 data
points for the 100-min and 1,000-min profiles, taken from the smoothed
splines (black lines) in Fig. 2A. The total number of 233 = 73 + 80 + 80 input
data points is necessarily higher than the number of 162 free-energy and dif-
fusivity parameters we need to determine. The profile ci(t = 0) corresponds
to the initial condition where DXM is homogeneously distributed in the gel
only. For minimization of the error function Eq. 6 we use the trust-region
iteration approach (42, 43); see Trust-Region Optimization for Constrained
Nonlinear Problems for details. As an initial guess for the minimization we
use a flat free-energy profile and choose random values for D(z) in the range
[10−1, . . . , 103] µm2/s. We perform 1,000 runs with different initial values
for D(z) with a maximal number of 250 iterations per run. For our results, we
use only the best 1% of solutions with a residual error σ< 0.6 µg/(cm2·µm).
A perfect solution with an error of σ= 0 is never observed, which reflects
that our equation system is overdetermined and at the same time input
concentration profiles come from different skin samples. In the constant-F
and constant-D models we obtains errors σ< 1.6 µg/(cm2·µm) and σ< 0.9
µg/(cm2·µm) for the best 1% of the solutions, significantly larger than for
the full model.
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